Further research is needed to inform whether primary care-based interventions for hypertension and other cardiovascular conditions, which include angiotensin II lowering approaches, might be amenable to primary intervention opportunities to reduce the incidence and progression of Alzheimer's disease, rather than being used as treatments later in the disease course. Here, AGT is linked to hypertensive disorder.